NANI Patient Care Innovations

Joint Ventures with NANI Patient Care Innovations

Nephrology Associates of Northern Illinois, LTD (KCE participant) has a joint venture with NANI Patient Care Innovations, LLC (KCE legal entity)

Governing Body

Arthur Morris, M.D., Nephrology Associates of Northern Illinois/Indiana
Manish Tanna, M.D., F.A.S.N., F.A.C.P., Nephrology Associates of Northern Illinois/Indiana
Brian J. O’Dea, C.P.A., Nephrology Associates of Northern Illinois/Indiana
Scott Schiffner, Consumer Advocate, Image Systems and Business Solutions
Benjamin Kuhn, Strive Health TX
Will Stokes, Strive Health
Sumair Akhtar, MD, Strive Health

Shared Savings and Losses

•The proportion of any Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries: Will be posted when results are available
•The proportion of Shared Savings distributed to KCE Participants and Preferred Providers:

•Quality Measure Performance:
Gains in Patient Activation Scores at 12 months ("PAM")
Depression Response at 12 months-Progress Toward Remission
Optimal ESRD Starts
Will be posted when results are available

Quality Measure Performance

Quality Measure Performance will be determined and reported after Performance Year 1 and in the timeframe determined by CMS Innovation Center. More information can be found at Kidney Care Choices KCC Model

Benefit Enhancements

Our KCE has elected to provide the following benefit enhancements to our CKD 4, 5, and ESRD patients to facilitate optimal care.

    Kidney Disease Education:

According to the Kidney Care Choices Model Operating Guide: Benefit Enhancements, the KDE benefit is intended to ensure beneficiaries are informed about the effects and treatment of kidney disease, diet and nutrition, transplantation, dialysis modalities, and vascular access. The education benefit is crucial to increasing rates of transplants and home dialysis and delaying the onset of ESRD. The education benefit has been expanded to include beneficiaries with CKD 4, 5 and the 1st 6months of ESRD.

    Post Discharge Home Visits:
Evidence suggests that home and domiciliary visits reduce the likelihood of readmission within 30 days of discharge from an inpatient stay for patients with chronic conditions. The research also indicates lower clinical risk for inpatient admission and lower costs for high-risk patients at 6-month follow-up. This Benefit Enhancement encourages providers to expand home visits for beneficiaries with multiple chronic conditions and a recent discharge from a health care facility.

    Telehealth Expansion:
Continued availability of telehealth benefits for attributed beneficiaries of CKCC.